Using tranexamic acid to reduce blood loss during vaginal hysterectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of local tranexamic acid in minimizing blood loss during vaginal hysterectomy procedures. Participants will be randomly assigned to receive either a local injection of tranexamic acid or a placebo (saline) at the start of the surgery. The study will measure the amount of blood loss during the operation to determine if tranexamic acid can significantly reduce bleeding. This approach could provide a simple and effective method to enhance surgical outcomes for patients undergoing this procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 20-90 years old female patients going through vaginal hysterctomy

Exclusion Criteria:

* massive bleeding during operation due to major vessles injury
* known coagulopathies
* sensitivity to tranexamic acid
* medical need in tranexamic acid administration during operation due to bleeding

Where it's running

• Meir medical center
  Kfar Saba, Israel Recruiting
• Meir Medical Center
  Kfar Saba, Israel, Israel Not yet recruiting

Study contacts

• Study coordinator: Yair Daykan, M.D
• Email: yair.dykan@gmail.com
• Phone: 0542198231

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Uterine artery ligation versus pericervical tourniquet to reduce bleeding during open myomectomy

  This trial will test whether tying the uterine arteries or using a pericervical tourniquet better reduces blood loss during open myomectomy for women with symptomatic uterine fibroids.

  Recruiting Cairo University · Cairo, Al-Manial · NCT07526311

• Low-dose epinephrine with tranexamic acid during knee replacement

  This will test whether giving low-dose epinephrine together with tranexamic acid to people having knee replacement reduces blood loss, clotting complications, and hospital stay.

  Recruiting Phase 4 King Abdullah International Medical Research Center · Riyadh, Riyadh Region · NCT07089251

• Tranexamic acid to reduce bleeding during second-trimester dilation and evacuation

  We will test whether giving prophylactic tranexamic acid before a second-trimester dilation and evacuation reduces bleeding for people aged 18 and older at 18–24 weeks of pregnancy.

  Recruiting at 3 sites Phase 4 University of California, San Diego · San Diego, California and 2 other locations · NCT06820177

• Evaluating outcomes of pregnancies with genital bleeding after 18 weeks

  This study looks at how often serious problems happen in pregnancies with bleeding after 18 weeks to see if better ultrasound techniques can help doctors manage these cases.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT06802874

• Monitoring transfusions during anesthesia in emergency situations

  This study is looking at how blood transfusions are done during emergency surgeries to help improve future treatment guidelines for patients.

  Recruiting Erasme University Hospital · Anderlecht · NCT06403163

• Investigating how oxytocin works during cesarean deliveries

  This study is testing how oxytocin works during scheduled cesarean deliveries to see if it helps prevent complications like uterine atony in new mothers.

  Recruiting Phase 2 Stanford University · Stanford, California and 1 other locations · NCT05488457

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.